Table of Contents
| << Previous Issue | Aug 2025 (Vol: 2025, Issue: 8) | Next Issue >> |
- Section: Licensing
-
AbbVie Signs US$1.225 B Licensing Pact with IGI Therapeutics for Oncology and Autoimmune Disease Treatment
- Section: Mergers & Acquisitions
-
Sino Biopharmaceutical Expands Oncology Portfolio with US$950.9 M Acquisition of LaNova Medicines
-
Sanofi to Acquire Vicebio for up to US$1.6 B
- Section: Research & Development
-
GSK Secures US$12 B Collaboration with Hengrui Pharma to Advance Respiratory, Immunology and Oncology Pipeline
-
Lilly Signs US$856 M Licensing Pact with Gate Bioscience to Develop Molecular Gate Therapeutics



RSS